Sun Pharma Advanced Research Company has informed that a meeting of the Board of Directors of the Company will be held on October 28, 2016, to consider and take on record, the un-audited financial results of the Company for the quarter and half year ended September 30, 2016 (Q2). Further note that, the trading window for trading by designated persons shall be closed from October 19, 2016 to November 02, 2016 in view of the above.
The above information is a part of company’s filings submitted to BSE.
